Quantitative assay for ciprofloxacin and enrofloxacin formulations
# Background Ciprofloxacin (cipro) is a broad-spectrum fluoroquinolone antibiotic active against both Gram-positive and Gram-negative bacteria. It is used extensively in both animals and humans due to its high bioavailability and the wide range of susceptible infections. However, the use of substan...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Inishmore Laser Scientific Publishing Ltd
2019-08-01
|
| Series: | Journal of Global Health Reports |
| Online Access: | https://doi.org/10.29392/joghr.3.e2019044 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850101218900180992 |
|---|---|
| author | Saundria Moed Mackenzie Hall Norman Lee Clarissa Prazeres da Costa Ernst K Rødland Atena I Shemirani Katie Clifford Darash Desai Muhammad H Zaman |
| author_facet | Saundria Moed Mackenzie Hall Norman Lee Clarissa Prazeres da Costa Ernst K Rødland Atena I Shemirani Katie Clifford Darash Desai Muhammad H Zaman |
| author_sort | Saundria Moed |
| collection | DOAJ |
| description | # Background
Ciprofloxacin (cipro) is a broad-spectrum fluoroquinolone antibiotic active against both Gram-positive and Gram-negative bacteria. It is used extensively in both animals and humans due to its high bioavailability and the wide range of susceptible infections. However, the use of substandard (poor quality) and counterfeit formulations of cipro in low- and middle-income countries has contributed to an increased risk of treatment failure due to antimicrobial resistance (AMR). Poor quality medicines especially have been linked to AMR. Therefore, there is a pressing need to screen for quality of cipro in low-resource settings.
# Methods
We have addressed this need by developing a low-cost fluorescence assay capable of quantifying the amount of cipro in tablets. In this assay, cipro is dissolved in deionized water and mixed with palladium(II) and methyl cellulose. Upon addition of these reagents, quenching of cipro is observed and quantified.
# Results
We demonstrated our assay with three brands of cipro, quantifying the tablets to within 3% error of the gold-standard, high-performance liquid chromatography. We extended this assay to assess the quality of enrofloxacin (enro), another fluoroquinolone primarily used in veterinary medicine, within 5% error of the package indication.
# Conclusions
These assays can be used to assess the quality of cipro and enro tablets in the field and identify substandard tablets, potentially helping to remove those tablets from circulation and decrease acceleration of AMR to cipro and enro. These assays can be easily adapted to previously-developed portable microfluidic platforms capable of assessing medicine quality in the field. |
| format | Article |
| id | doaj-art-23ddd954a67e4182acf93cd36097817e |
| institution | DOAJ |
| issn | 2399-1623 |
| language | English |
| publishDate | 2019-08-01 |
| publisher | Inishmore Laser Scientific Publishing Ltd |
| record_format | Article |
| series | Journal of Global Health Reports |
| spelling | doaj-art-23ddd954a67e4182acf93cd36097817e2025-08-20T02:40:06ZengInishmore Laser Scientific Publishing LtdJournal of Global Health Reports2399-16232019-08-01310.29392/joghr.3.e2019044Quantitative assay for ciprofloxacin and enrofloxacin formulationsSaundria MoedMackenzie HallNorman LeeClarissa Prazeres da CostaErnst K RødlandAtena I ShemiraniKatie CliffordDarash DesaiMuhammad H Zaman# Background Ciprofloxacin (cipro) is a broad-spectrum fluoroquinolone antibiotic active against both Gram-positive and Gram-negative bacteria. It is used extensively in both animals and humans due to its high bioavailability and the wide range of susceptible infections. However, the use of substandard (poor quality) and counterfeit formulations of cipro in low- and middle-income countries has contributed to an increased risk of treatment failure due to antimicrobial resistance (AMR). Poor quality medicines especially have been linked to AMR. Therefore, there is a pressing need to screen for quality of cipro in low-resource settings. # Methods We have addressed this need by developing a low-cost fluorescence assay capable of quantifying the amount of cipro in tablets. In this assay, cipro is dissolved in deionized water and mixed with palladium(II) and methyl cellulose. Upon addition of these reagents, quenching of cipro is observed and quantified. # Results We demonstrated our assay with three brands of cipro, quantifying the tablets to within 3% error of the gold-standard, high-performance liquid chromatography. We extended this assay to assess the quality of enrofloxacin (enro), another fluoroquinolone primarily used in veterinary medicine, within 5% error of the package indication. # Conclusions These assays can be used to assess the quality of cipro and enro tablets in the field and identify substandard tablets, potentially helping to remove those tablets from circulation and decrease acceleration of AMR to cipro and enro. These assays can be easily adapted to previously-developed portable microfluidic platforms capable of assessing medicine quality in the field.https://doi.org/10.29392/joghr.3.e2019044 |
| spellingShingle | Saundria Moed Mackenzie Hall Norman Lee Clarissa Prazeres da Costa Ernst K Rødland Atena I Shemirani Katie Clifford Darash Desai Muhammad H Zaman Quantitative assay for ciprofloxacin and enrofloxacin formulations Journal of Global Health Reports |
| title | Quantitative assay for ciprofloxacin and enrofloxacin formulations |
| title_full | Quantitative assay for ciprofloxacin and enrofloxacin formulations |
| title_fullStr | Quantitative assay for ciprofloxacin and enrofloxacin formulations |
| title_full_unstemmed | Quantitative assay for ciprofloxacin and enrofloxacin formulations |
| title_short | Quantitative assay for ciprofloxacin and enrofloxacin formulations |
| title_sort | quantitative assay for ciprofloxacin and enrofloxacin formulations |
| url | https://doi.org/10.29392/joghr.3.e2019044 |
| work_keys_str_mv | AT saundriamoed quantitativeassayforciprofloxacinandenrofloxacinformulations AT mackenziehall quantitativeassayforciprofloxacinandenrofloxacinformulations AT normanlee quantitativeassayforciprofloxacinandenrofloxacinformulations AT clarissaprazeresdacosta quantitativeassayforciprofloxacinandenrofloxacinformulations AT ernstkrødland quantitativeassayforciprofloxacinandenrofloxacinformulations AT atenaishemirani quantitativeassayforciprofloxacinandenrofloxacinformulations AT katieclifford quantitativeassayforciprofloxacinandenrofloxacinformulations AT darashdesai quantitativeassayforciprofloxacinandenrofloxacinformulations AT muhammadhzaman quantitativeassayforciprofloxacinandenrofloxacinformulations |